Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-034817
Filing Date
2025-11-13
Accepted
2025-11-13 16:08:17
Documents
90
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q iccc20250930_10q.htm   iXBRL 10-Q 2228655
2 EXHIBIT 31.1 ex_856385.htm EX-31.1 7604
3 EXHIBIT 31.2 ex_877308.htm EX-31.2 8299
4 EXHIBIT 32.1 ex_856387.htm EX-32.1 5382
5 EXHIBIT 32.2 ex_877309.htm EX-32.2 5692
  Complete submission text file 0001437749-25-034817.txt   11181485

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA iccc-20250930.xsd EX-101.SCH 75240
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE iccc-20250930_cal.xml EX-101.CAL 49028
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iccc-20250930_def.xml EX-101.DEF 539778
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE iccc-20250930_lab.xml EX-101.LAB 460729
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iccc-20250930_pre.xml EX-101.PRE 579865
93 EXTRACTED XBRL INSTANCE DOCUMENT iccc20250930_10q_htm.xml XML 2421138
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 251478467
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)